Home » Science »

Biotechnology

Biotechnology

News in this category: 49
Bookmark and share this category:  

News

People protest outside the White House on February 4, 2017Bosses of more than 150 US biotech companies Tuesday criticised US President Donald Trump's travel ban against seven Muslim-majority countries, saying the sector stood to lose talented workers and its global dominance. The United States is the world's greatest developer of new medicines, a position reached by being able "to attract the best talent, wherever it is found," they wrote in a letter to science journal Nature Biotechnology. The letter bears the signatures of 166 founders and leaders of pharma and biotech companies such as Biogen, Ironwood Pharmaceuticals and Incyte, along with research institutions including the Massachusetts Institute of Technology and Harvard Business School.
Genetic hearing disorders affect some 125 million people worldwide, according to the World Health OrganizationGene therapy delivered by a benign virus enabled deaf lab mice to hear for the first time, researchers said Monday, offering hope for people with genetic hearing impairments. The breakthrough could pave the way for gene-based treatments, they reported in two studies, published in Nature Biotechnology. "With more than 100 genes already known to cause deafness in humans, there are many patients who may eventually benefit from this technology," said Konstantina Stankovic, a professor at Harvard Medical School.
Doctors often fail to recommend or even discuss genetic testing of women at high risk for mutations associated with breast or ovarian cancer, a new study published Tuesday has found. "Women are very interested in genetic testing but many fail to receive it," said Allison Kurian, a Stanford University Medical School professor and lead author of the study published in JAMA, the Journal of the American Medical Association. Kurian and researchers at the University of Michigan based their findings on a survey of more than 2,500 women with stage 0 to stage 2 cancer two months after surgery.
A Bolivian woman inspects a Quinoa plant, a variety of grain cultivated in high altitudes, during a visit to the area by journalists with the Bolivian government, to promote the International Year of Quinoa in TarmayaBy Will Dunham WASHINGTON (Reuters) - Quinoa, the sacred "mother grain" of the ancient Inca civilization suppressed by Spanish conquistadors, could become an increasingly important food source in the future thanks to genetic secrets revealed in a new study. Scientists on Wednesday said they have mapped the genome of quinoa and identified a gene that could be manipulated to get rid of the grain's natural bitter taste and pave the way for more widespread commercial use. Quinoa (pronounced KIN-wah) already grows well in harsh conditions such as salty and low-quality soil, high elevations and cool temperatures, meaning it can flourish in locales where common cereal crops like wheat and rice may struggle.
The Alachua, Florida-based company said it had profit of 11 cents per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
FILE PHOTO - A man holds quinoa grains at a marketplace for small and medium-sized quinoa growers in Challapata south of La PazBy Will Dunham WASHINGTON (Reuters) - Quinoa, the sacred "mother grain" of the ancient Inca civilization suppressed by Spanish conquistadors, could become an increasingly important food source in the future thanks to genetic secrets revealed in a new study. Scientists on Wednesday said they have mapped the genome of quinoa and identified a gene that could be manipulated to get rid of the grain's natural bitter taste and pave the way for more widespread commercial use. Quinoa (pronounced KIN-wah) already grows well in harsh conditions such as salty and low-quality soil, high elevations and cool temperatures, meaning it can flourish in locales where common cereal crops like wheat and rice may struggle.
FILE PHOTO - A man holds quinoa grains at a marketplace for small and medium-sized quinoa growers in Challapata south of La PazBy Will Dunham WASHINGTON (Reuters) - Quinoa, the sacred "mother grain" of the ancient Inca civilization suppressed by Spanish conquistadors, could become an increasingly important food source in the future thanks to genetic secrets revealed in a new study. Scientists on Wednesday said they have mapped the genome of quinoa and identified a gene that could be manipulated to get rid of the grain's natural bitter taste and pave the way for more widespread commercial use. Quinoa (pronounced KIN-wah) already grows well in harsh conditions such as salty and low-quality soil, high elevations and cool temperatures, meaning it can flourish in locales where common cereal crops like wheat and rice may struggle.
By Ben Hirschler LONDON (Reuters) - Two babies rescued from previously incurable leukemia after receiving infusions of gene-edited immune cells are doing well at home more than a year after initial treatment, scientists said on Wednesday. Layla Richards became the first person in the world to get the "off-the-shelf" cell therapy developed by French biotech firm Cellectis at Britain's Great Ormond Street Hospital in 2015. Waseem Qasim, a consultant immunologist at the London hospital, said the two cases showed the gene-edited cells were working, although long term monitoring was still required.
To expand the list of height-related genes, a team used new technology to test participants for less common, hard-to-detect variationsResearchers on Wednesday unveiled 83 rare gene variants which exert a strong influence on human height, with some capable of adding or subtracting more than two centimetres (0.8 inches). Previous research had shown that genetic inheritance determines more than 80 percent of a person's height. "Our latest discovery means that we can now explain over a quarter of the heritable factors involved in influencing a person's height," said Andrew Wood of the University of Exeter, a co-author of the study, published in the journal Nature.
Highland Therapeutics Inc has raised $200 million from Morgan Stanley ahead of the U.S. drug regulator's decision for a new drug that manages attention deficit hyperactivity disorder (ADHD), the Toronto-based biotech startup said on Tuesday. The drug HLD200, which underwent two Phase 3 studies last year, is under review and awaiting approval by the U.S. Food and Drug Administration. Part of the financing is contingent on the FDA decision, which is expected on July 30.
Gene Cernan, last astronaut to walk on the moon, dies at 82Former astronaut Gene Cernan, who as the last person to walk on the moon returned to Earth with a message of "peace and hope for all mankind," died on Monday, his family said. He was 82. Cernan ...
FILE - In an undated file photo provided by NASA, US Navy Commander and Astronaut for the upcoming Apollo 17, Eugene Cernan, is pictured in his space suit. NASA announced that former astronaut Cernan, the last man to walk on the moon, died Monday, Jan. 16, 2017, surrounded by his family. He was 82. (NASA via AP)HOUSTON (AP) — Astronaut Gene Cernan traced his only child's initials in the dust of the lunar surface. Then he climbed into the lunar module for the ride home, becoming the last person to walk on the moon.
FORMER ASTRONAUT GENE CERNAN WITH LUNAR PHOTOGRAPHS IN NEW YORK.Cernan, who was also the second American to walk in space, died surrounded by his family, the National Aeronautics and Space Administration said in a statement without providing details. Cernan and fellow Apollo 17 astronaut Harrison Schmitt became members of the most exclusive club in the universe on Dec. 11, 1972, when they stepped from their lunar landing module onto the moon's surface. "Oh, my golly," Cernan told mission control in Houston as he touched the moon.
FILE - In an undated file photo provided by NASA, US Navy Commander and Astronaut for the upcoming Apollo 17, Eugene Cernan, is pictured in his space suit. NASA announced that former astronaut Cernan, the last man to walk on the moon, died Monday, Jan. 16, 2017, surrounded by his family. He was 82. (NASA via AP)HOUSTON (AP) — Astronaut Gene Cernan traced his only child's initials in the dust of the lunar surface. Then he climbed into the lunar module for the ride home, becoming the last person to walk on the moon.
FORMER ASTRONAUT GENE CERNAN WITH LUNAR PHOTOGRAPHS IN NEW YORK.Cernan, who was also the second man to walk in space, died surrounded by his family, the National Aeronautics and Space Administration said in a statement without providing details. Cernan and fellow Apollo 17 astronaut Harrison Schmitt became members of the most exclusive club in the universe on Dec. 11, 1972, when they stepped from their lunar landing module onto the moon's surface. "Oh, my golly," Cernan told mission control in Houston as he touched the moon.
U.S. President-elect Donald Trump leaves a press conference in Trump Tower, Manhattan, New YorkU.S. President-elect Donald Trump has left the agriculture secretary as the last department head to be named to his Cabinet, while a meeting with the chief executives of two agribusiness giants gave a hint at a roster of farm issues the incoming president will face. Trump met on Wednesday with the leaders of Monsanto Co and Bayer AG , who pitched the benefits of their proposed $66 billion merger. While critical of other large tie-ups, Trump has not publicly taken a stance on the Bayer-Monsanto deal.
Investors in large U.S. pharmaceutical and biotech companies are counting on strong dividends, reasonable stock valuations and new products to help ride out a storm of political uncertainty as the incoming Trump administration dives into healthcare policy. The sector took a pounding on Wednesday after U.S. president-elect Donald Trump said the drug industry was "getting away with murder" on medicine costs, suggesting that the specter of government actions on pricing is not going away any time soon. "We do think they are generating a lot of cash, throwing out a very nice dividend and the valuations are more reasonable than many areas of the market," said David Katz, chief investment officer at Matrix Asset Advisors in New York, which owns stock in Merck , Pfizer , AbbVie and Gilead .
The offices of gene sequencing company Illumina Inc are shown in San Diego, California(Reuters) - Shares of Illumina Inc rose 16 percent on Tuesday, after the company unveiled new technology, which is expected to eventually reduce the cost of sequencing to $100 per human genome, prompting a slew of price target increases. It took government-funded scientists $3 billion and 13 years to sequence the first human genome by 2003. Illumina on Monday unveiled its NovaSeq sequencing platform, which is expected to deliver three-times faster and twenty percent cheaper sequencing over existing models.
U.S. Supreme Court Chief Justice John Roberts speaks at the dedication of the Smithsonian?s National Museum of African American History and Culture in WashingtonU.S. Chief Justice John Roberts will no longer participate in a patent dispute at the Supreme Court involving a unit of Thermo Fisher Scientific Inc after he realized he owns about $175,000 of stock in the company, the court said on Wednesday. The eight-justice court is weighing whether genetic-testing kits made by Thermo Fisher-owned Life Technologies Corp infringed upon patents held by Promega Corp. In a letter issued on Wednesday, Scott Harris, the clerk of the court, said Roberts belatedly learned that Life Technologies was owned by Thermo Fisher.
The Food and Drug Administration on Friday approved the first treatment for children and adults with spinal muscular atrophy, a rare genetic disorder marked by progressive muscle weakness that's the most ...
The U.S. Food and Drug Administration on Friday said it has approved Biogen Inc's drug to treat spinal muscular atrophy, the leading genetic cause of death in infants. It is the first FDA-approved medicine for spinal muscular atrophy, a devastating disease that affects about one in 10,000 live births. The drug, nusinersen, which was discovered by Ionis Pharmaceuticals and licensed to Biogen, will be sold under the brand name Spinraza.
In this Nov. 28, 2016 photo, Dr. Si Pham, left, injects stem cells into Josue Salinas Salgado alongside Dr. Sunjay Kaushal, center, during open heart surgery at the University of Maryland Medical Center in Baltimore. (AP Photo/Patrick Semansky)BALTIMORE (AP) — The 4-month-old on the operating table has a shocking birth defect, nearly half his heart too small or even missing. To save him, surgeons will have to totally reroute how his blood flows, a drastic treatment that doesn't always work.
A seahorse swims in a tank at the Underwater World Aquarium in Pattaya, nearly 145 km (90 miles) east of BangkokBy Will Dunham WASHINGTON (Reuters) - Scientists have unlocked some of the genetic secrets of the weird and wondrous seahorse including its exotic eccentricity of male pregnancy. Researchers said on Wednesday they sequenced the genome of a seahorse species for the first time and identified the genetic underpinning for certain peculiarities in this equine-looking fish group that inhabits coastal waters around the world. Seahorses boast a host of oddities.
SEOUL, South Korea (AP) — Samsung Biologics Co., the contract drug making unit of Samsung Group, made its market debut in Seoul on Thursday in South Korea's largest initial public offering in six years.
Signage for GlaxoSmithKline is seen on it's offices in London, BritainGlaxoSmithKline's new injectable asthma drug Nucala has been recommended for use in Britain's state-run health service in the most severe patients, after the drugmaker provided further analyses on its use and made an additional price cut.